Broach Lifecare

Why is Broach Lifecare Hospital Ltd falling/rising?

As of 18-Jul, Broach Lifecare Hospital Ltd's stock price is stable at 14.20, with short-term gains but a significant decline of 18.44% over the past month and 35.45% over the past year, indicating longer-term weakness and reduced investor participation.

As of 18-Jul, Broach Lifecare Hospital Ltd's stock price is currently stable at 14.20, showing no change (0.00%). The stock has experienced a mixed performance in recent periods. Over the past week, it has not changed, while it has seen a significant decline of 18.44% over the past month and a notable drop of 35.45% over the past year. However, year-to-date, the stock has risen by 8.40%, contrasting with the Sensex, which has decreased by 8.30% during the same period.<BR><BR>Today, the stock has outperformed its sector by 3.66% and has gained 5.89% over the last two days, indicating a short-term positive trend. Despite this recent gain, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which suggests a longer-term weakness. Additionally, there has been a significant decline in investor participation, with delivery volume dropping by 54.55% compared to the 5-day average, indicating reduced interest from investors.<BR><BR>In summary, while there are short-term gains and outperformance against the sector, the overall trend shows a decline in the stock's value over longer periods, coupled with decreasing investor participation, which may contribute to the stock's current stability at 14.20.

Which are the latest news on Broach Lifecare?

What does Broach Lifecare do?

Broach Lifecare Hospital Ltd, incorporated in April 2023, operates in the hospital industry and has acquired Dr. Vyas's Heart Hospital and Dr. Vyas Hospital. It is a micro-cap company with no reported sales or profits, a market cap of INR 9 Cr, and key metrics indicating a high P/E ratio of 115.00.

Overview: <BR>Broach Lifecare Hospital Ltd operates in the hospital industry and is categorized as a micro-cap company.<BR><BR>History: <BR>Broach Lifecare Hospital Ltd was incorporated on April 25, 2023, as "Broach Lifecare Hospital Private Limited." The company acquired the sole proprietorship concerns of Dr. Jaykumar Narendra Vyas, which includes Dr. Vyas's Heart Hospital and Dr. Vyas Hospital, through a Business Transfer Agreement dated July 17, 2023. There is no sales or profit data reported for any quarter.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 9 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 115.00 <BR>Industry P/E: N/A <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.07 <BR>Return on Equity: 0.93% <BR>Price-to-Book: 0.94 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

How big is Broach Lifecare?

As of 10th June, Broach Lifecare Hospital Ltd has a market capitalization of 9.00 Cr, classifying it as a Micro Cap, with no valid financial data available for Net Sales or Net Profit for the latest four quarters. The latest balance sheet shows Shareholder's Funds of 9.36 Cr and Total Assets of 10.92 Cr as of March 2025.

As of 10th June, <BR><BR>Market Cap: Broach Lifecare Hospital Ltd has a market capitalization of 9.00 Cr, categorizing it as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The latest reporting period is March 2025, with Shareholder's Funds amounting to 9.36 Cr and Total Assets of 10.92 Cr.

Who are the peers of the Broach Lifecare?

Broach Lifecare's peers include Fortis Malar, Shanmuga Hospital, Soni Medicare, KK Shah Hospital, Global Longlife, Docmode Health, Nidan Laboratories, Aatmaj Health, and Sangani Hospital. In terms of returns, Soni Medicare leads with 43.70% over one year, while Broach Lifecare has a return of -20.98%.

Peers: The peers of Broach Lifecare are Fortis Malar, Shanmuga Hos., Soni Medicare, KK Shah Hospital, Global Longlife, Docmode Health, Nidan Laborator., Aatmaj Health, Sangani Hospital.<BR><BR>Quality Snapshot: Below Average management risk is observed at Fortis Malar, Soni Medicare, KK Shah Hospital, Global Longlife, Broach Lifecare, Docmode Health, Nidan Laborator., and Maitreya Medica. Average management risk is found at Shanmuga Hos. and Aatmaj Health. Excellent management risk is noted at Sangani Hospital, while Good capital structure is seen at KK Shah Hospital, Broach Lifecare, and Aatmaj Health. Below Average capital structure is present at Fortis Malar, Soni Medicare, Global Longlife, Docmode Health, Nidan Laborator., and Maitreya Medica.<BR><BR>Return Snapshot: Soni Medicare has the highest 1-year return at 43.70%, while Global Longlife has the lowest at -55.83%. Broach Lifecare's 1-year return is -20.98%, which is higher than Global Longlife's but lower than Soni Medicare's. Additionally, Global Longlife, Docmode Health, Nidan Laborator., and Maitreya Medica have negative six-month returns.

When is the next results date for Broach Lifecare Hospital Ltd?

The next results date for Broach Lifecare Hospital Ltd is 21 May 2026.

The next results date for Broach Lifecare Hospital Ltd is scheduled for 21 May 2026.

Is Broach Lifecare overvalued or undervalued?

As of November 17, 2025, Broach Lifecare is considered very attractive and undervalued with a PE ratio of 19.11, significantly lower than its peers, indicating strong growth potential despite a year-to-date stock performance lagging behind the Sensex.

As of 17 November 2025, Broach Lifecare's valuation grade has moved from attractive to very attractive, indicating a significant improvement in its perceived value. The company is currently assessed as undervalued, with a PE ratio of 19.11, an EV to EBIT ratio of 9.65, and a Price to Book Value of 1.07. These metrics suggest that Broach Lifecare is trading at a lower valuation compared to its peers in the healthcare sector.<BR><BR>In comparison to its peers, Broach Lifecare's PE ratio of 19.11 is notably lower than Apollo Hospitals at 64.41 and Narayana Hrudaya at 48.72, both of which are considered expensive. Additionally, the PEG ratio for Broach Lifecare stands at 0.00, indicating strong growth potential relative to its price, especially when contrasted with peers like Max Healthcare, which has a PEG ratio of 2.30. Despite the company's recent stock performance lagging behind the Sensex, with a year-to-date return of -21.3% compared to the Sensex's 8.72%, the underlying valuation metrics suggest that Broach Lifecare presents a compelling investment opportunity at its current price of 17.00.

How has been the historical performance of Broach Lifecare?

Broach Lifecare's historical performance from March 2024 to March 2025 shows increased net sales and shareholder equity, but a decline in profitability metrics and negative cash flow from investing activities indicate financial challenges.

Answer:<BR>The historical performance of Broach Lifecare shows a mixed trend in financial metrics from March 2024 to March 2025.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Broach Lifecare reported net sales of 3.18 Cr, an increase from 2.61 Cr in the previous year. Total operating income also rose to 3.18 Cr from 2.61 Cr, while total expenditure increased to 2.35 Cr from 1.58 Cr. Operating profit (PBDIT) decreased to 0.88 Cr from 1.03 Cr, leading to a decline in profit before tax to 0.72 Cr from 0.93 Cr. Consequently, profit after tax fell to 0.54 Cr from 0.70 Cr. The earnings per share (EPS) dropped to 0.89 from 1.57, reflecting a decrease in profitability. On the balance sheet, shareholder's funds grew to 9.36 Cr from 5.47 Cr, and total liabilities increased to 10.92 Cr from 5.72 Cr. The company reported a cash flow from financing activities of 4.00 Cr, consistent with the previous year, while cash flow from investing activities showed a negative trend at -3.00 Cr, worsening from -1.00 Cr. Overall, while Broach Lifecare experienced growth in sales and shareholder equity, profitability metrics and cash flow from operations indicate challenges in maintaining financial health.

Who are the top shareholders of the Broach?

The top shareholder of Broach is Jaykumar Narendra Vyas, holding 63.75% of the shares, with no pledged promoter holdings. The highest public shareholder is Kaushik Bhupatrai Joshi at 5.27%, while individual investors collectively own 33.77%.

The top shareholders of Broach include the promoters, with Jaykumar Narendra Vyas holding the largest share at 63.75%. There are no pledged promoter holdings, and mutual funds and foreign institutional investors do not hold any shares in the company. The highest public shareholder is Kaushik Bhupatrai Joshi, who owns 5.27%. Additionally, individual investors collectively hold 33.77% of the shares.

Has Broach declared dividend?

No Dividend History Available